Solid tissues can be manipulated <i>ex vivo</i> and used as vehicles for gene therapy

Eilat Hasson, Y. Slovatizky, Yael Shimoni, Haya Falk, Amos Panet, Eduardo Mitrani

The Journal of Gene Medicine · 2005 · 31 citations · 31 references

Concepts

TL;DR

Organ fragments can be cultured for weeks in vitro when prepared at microscopic thickness while preserving basic organ structure. The authors exploited this methodology to engineer micro‑organs ex vivo by gene transfer. Micro‑organs from spleen, lung, colon, and skin were infected with herpes simplex type‑1, adenovirus, vaccinia virus, and murine leukemia virus carrying a β‑galactosidase reporter. All four viral vectors infected the micro‑organs, with adenovirus and MuLV achieving >15 % β‑galactosidase‑positive cells; the engineered tissues remained localized, vascularized, and expressed the transgene for months after implantation, demonstrating a platform for ex vivo gene therapy and for studying virus–tissue interactions in vivo. © 2005 John Wiley & Sons, Ltd.

Abstract

Abstract Background Organ fragments can be cultured for weeks in vitro if they are prepared of microscopic thickness and if the basic organ structure is preserved. Such organ fragments, which we termed micro‐organs (MOs), express in culture endogenous tissue‐specific gene products. We have exploited this methodology to engineer MOs ex vivo by gene transfer. Methods MOs prepared from spleen, lung, colon and skin were infected using: herpes simplex type‐1, adeno virus, vaccinia virus and murine leukemia virus (MuLV), carrying the reporter gene β‐galactosidase. Results All four viral vectors infected MOs in culture, with adeno infection giving significantly higher values. After optimization, high levels of expression (&gt;15% positive cells), comparable to those obtained with the adeno construct, were also obtained using the MuLV construct both in vitro and after implantation into syngeneic hosts. After implantation, the engineered tissue was found to remain localized, become vascularized, and to express the transduced gene for several months. Conclusions The system can be used to study interactions between viruses and tissues both ex vivo and in vivo . Furthermore, the approach proposes a novel platform for ex vivo gene therapy. Such engineered structures could be used as autologous biological pumps for continuous secretion in vivo of gene products of clinical importance. Copyright © 2005 John Wiley &amp; Sons, Ltd.

References

31